Table 2.

Recommendations of expert panels for the use of corticosteroids in patients with SARS-COV2 pneumonia[44.47]

Indication for using corticosteroids should be based on an a priori risk-benefit analysis. Dexamethasone 6 mg once daily or equivalents (prednisone 40 mg, methylprednisolone 32 mg, hydrocortisone 160 mg) is the daily dosage recommended. Hydrcortisone having the shorter half-life should be used in patients with SARS-COV2 and sepsis. Corticosteroids are recommended in patients with severe SARS-COV2 infection requiring high-flow oxygen and/or mechanical ventilation and as an alternative to remdesivir in patients with hypoxemia not requiring high oxygen flows. In patients with non-severe SARS-COV 2 infection corticosteroids use should rather be restrictive, and not recommended in patients without hypoxemia or with no need for hospitalization A short course ≤ 7 days being indicated.